Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy of Methylprednisolone for Hantavirus Cardiopulmonary Syndrome
This study is currently recruiting participants.
Study NCT00128180 Information provided by University of New Mexico
First Received: August 5, 2005 Last Updated: September 23, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hantavirus Infections
Additional conditions recognized in this trial
Infection
Syndrome
More general conditions related to this trial
Bunyaviridae Infections
Disease
Pathologic Processes
RNA Virus Infections
Virus Diseases
Interventions listed in this trial
Methylprednisolone
Placebo
Additional drug interventions recognized in this trial
Methylprednisolone acetate
Methylprednisolone Hemisuccinate
Prednisolone
Prednisolone acetate
More general drug interventions related to this trial
Anti-Inflammatory Agents
Antiemetics
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Autonomic Agents
Central Nervous System Agents
Gastrointestinal Agents
Glucocorticoids
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Neuroprotective Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Therapeutic Uses
Sponsors listed in this trial
University of New Mexico
National Institute of Allergy and Infectious Diseases (NIAID)
Back to top of Main Content